홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium hydride → 4-(6-Cyanooxindol-3-yl)-6-methoxy-7-(3-morpholinopropoxy)quinazoline

HRID 1386343
인쇄

반응식

HRID 1386343 반응식
[H-].[Na+].[C:3]([C:5]1[CH:13]=[C:12]2[C:8]([CH2:9][C:10](=[O:14])[NH:11]2)=[CH:7][CH:6]=1)#[N:4].Cl[C:16]1[C:25]2[C:20](=[CH:21][C:22]([O:28][CH2:29][CH2:30][CH2:31][N:32]3[CH2:37][CH2:36][O:35][CH2:34][CH2:33]3)=[C:23]([O:26][CH3:27])[CH:24]=2)[N:19]=[CH:18][N:17]=1>>[C:3]([C:5]1[CH:13]=[C:12]2[C:8]([CH:9]([C:16]3[C:25]4[C:20](=[CH:21][C:22]([O:28][CH2:29][CH2:30][CH2:31][N:32]5[CH2:33][CH2:34][O:35][CH2:36][CH2:37]5)=[C:23]([O:26][CH3:27])[CH:24]=4)[N:19]=[CH:18][N:17]=3)[C:10](=[O:14])[NH:11]2)=[CH:7][CH:6]=1)#[N:4]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 24758Sodium hydrideHCID 27733482-Oxindole-6-carbonitrileHCID 118239414-Chloro-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazoline

생성물 1

HCID 101952864-(6-Cyanooxindol-3-yl)-6-methoxy-7-(3-morpholinopropoxy)quinazoline수율 13.3%

실험 절차

Sodium hydride (80 mg, 2.07 mmol) was added to a solution of 6-cyanooxindole (280 mg, 1.78 mmol), (prepared as described for the starting material in Example 57), in dry, degassed DMF (10 ml) and the suspension stirred for 15 minutes at ambient temperature. A solution of 4-chloro-6-methoxy-7-(3-morpholinopropoxy)quinazoline (200 mg, 0.59 mmol), (prepared as described for the starting material in Example 5), in a dry, degassed mixture of DMF (2 ml) and THF (2 ml) was added dropwise and the reaction mixture was heated at 60° C. for 3 hours. The mixture was allowed to cool, the solvents were removed by evaporation and the residue was partitioned between ethyl acetate and water. The organic phase was separated and the aqueous phase extracted with ethyl acetate (50 ml×3). The ethyl acetate fractions were combined, dried (MgSO4), the solvent removed by evaporation and the residue was purified by flash column chromatography eluting with methylene chloride/methanol (100/13). The purified product was triturated in boiling ether and the solid product collected by filtration to give 4-(6-cyanooxindol-3-yl)-6-methoxy-7-(3-morpholinopropoxy)quinazoline (36 mg, 13%) as an orange solid.

후처리

  1. custom(prepared
  2. customin dry
  3. customdegassed DMF (10 ml)
  4. customdegassed
  5. additionmixture of DMF (2 ml) and THF (2 ml)
  6. additionwas added dropwise
  7. temperaturethe reaction mixture was heated at 60° C. for 3 hours
  8. temperatureto cool
  9. customthe solvents were removed by evaporation
  10. customthe residue was partitioned between ethyl acetate and water
  11. customThe organic phase was separated
  12. extractionthe aqueous phase extracted with ethyl acetate (50 ml×3)
  13. dry with materialdried (MgSO4)
  14. customthe solvent removed by evaporation
  15. customthe residue was purified by flash column chromatography
  16. washeluting with methylene chloride/methanol (100/13)
  17. customThe purified product was triturated
  18. filtrationthe solid product collected by filtration

출처 및 근거

ORD 기록
ord-cade34b43cba4955b6dd3c0c12f1f42f
출처 데이터셋
uspto-grants-2001_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06265411B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트